Zhitong Finance App News, Sunflower Pharmaceutical (002737.SZ) announced that the company plans to use its own capital of RMB 60 million to increase the capital of its subsidiary Sunflower Pharmaceutical Group (Jilin) Linjiang Co., Ltd. (“Linjiang Sunflower”). After the capital increase is completed, Linjiang Sunflower's registered capital will increase to 100 million yuan.

Zhitongcaijing · 11/26 07:57
Zhitong Finance App News, Sunflower Pharmaceutical (002737.SZ) announced that the company plans to use its own capital of RMB 60 million to increase the capital of its subsidiary Sunflower Pharmaceutical Group (Jilin) Linjiang Co., Ltd. (“Linjiang Sunflower”). After the capital increase is completed, Linjiang Sunflower's registered capital will increase to 100 million yuan.